Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
4.900
-0.170 (-3.35%)
Nov 21, 2024, 4:00 PM EST - Market closed
Nuvectis Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -19.37 | -22.26 | -19.09 | -12.89 | -0.02 |
| Stock-Based Compensation | 4.94 | 4.71 | 1.71 | 1.89 | - |
| Change in Accounts Payable | -1.23 | -0.14 | 1.85 | 1.59 | 0.02 |
| Change in Other Net Operating Assets | 2.04 | 1.74 | 1.97 | -0.09 | - |
| Operating Cash Flow | -13.63 | -15.95 | -13.56 | -9.5 | - |
| Issuance of Common Stock | 8.98 | 16.48 | 31.88 | - | - |
| Other Financing Activities | -0.24 | -1.39 | -4.07 | - | - |
| Financing Cash Flow | 8.74 | 15.09 | 27.81 | 15.25 | - |
| Net Cash Flow | -4.89 | -0.87 | 14.25 | 5.74 | - |
| Free Cash Flow | -13.63 | -15.95 | -13.56 | -9.5 | - |
| Free Cash Flow Per Share | -0.82 | -1.03 | -1.07 | -2.23 | - |
| Levered Free Cash Flow | -6.31 | -7.83 | -6.12 | - | - |
| Unlevered Free Cash Flow | -6.31 | -7.83 | -6.12 | - | - |
| Change in Net Working Capital | -0.81 | -1.15 | -3.45 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.